Fellows
Fellows in Committee on Clinical Pharmacology and Pharmacogenomics
Mohamed Ali, PhD
Fellow, Committee on Clinical Pharmacology and Pharmacogenomics
Research Interest:
Clinical Pharmacology and Translational Science. Focus on exposure-response analysis, PK modeling, and dose optimization through alternative dosing strategies in oncology, particularly within early-phase clinical trials to enhance efficacy, safety, and cost-effectiveness.
Research Mentor: Mark Ratain, MD
Marcel Bertsch-Gout, MD
Fellow, Committee on Clinical Pharmacology and Pharmacogenomics
Research Interest: Early phase clinical trials; improving the side effect profiles of psychiatric medications by increasing receptor specificity.
Research Mentors: Royce Lee, MD and Harriet de Witt, PhD
Robert Cameron, MD, PhD
Fellow, Committee on Clinical Pharmacology and Pharmacogenomics
Research Interest: Identification of metabolic vulnerabilities within tumors to develop new therapeutic targets and combinations
Research Mentors: Brandon Faubert, PhD and Marina Garassino, MD
Joseph Cannova, MD, PhD
Fellow, Committee on Clinical Pharmacology and Pharmacogenomics
Research Interest: Investigating mechanisms of recurrent cytogenetic alterations in therapy-related myelodysplastic syndrome and acute myeloid leukemia with loss of chromosome 7 domains.
Research Mentor: Michael Drazer, MD, PhD
Youngwoo Cho, PharmD
Fellow, Committee on Clinical Pharmacology and Pharmacogenomics
Research Interest: Translation of pharmacogenomics (PGx) in clinical oncology, early-phase clinical development, and pharmacokinetics (PK) and pharmacodynamics (PD) of immunotherapy
Research Mentor: Peter H. O’Donnell, MD
Sabrina Imam, MD, PhD
Fellow, Committee on Clinical Pharmacology and Pharmacogenomics
Research Interest: Characterizing the intestinal microbiome and metabolome in people undergoing chemotherapy in hopes of identifying metabolites associated with favorable clinical outcomes and protection from infection
Research Mentor: Eric G. Pamer, MD
Danica Quickfall, MDCM
Scholar, Committee on Clinical Pharmacology and Pharmacogenomics
Research Interest: Understanding sedative and antimicrobial administration in critically ill patients. Focus on optimizing antimicrobial dosing in patients receiving continuous renal replacement therapy and novel routes of medication administration
Research Mentor: Jay Koyner, MD
Sulin Wu, MD, PhD
Fellow, Committee on Clinical Pharmacology and Pharmacogenomics
Research Interest: Therapeutic design informed by germline and somatic profiles associated with immune therapy resistance and intolerance; Biomarker discovery; Early phase trials
Research Mentor: Olufunmilayo Olopade, MD, FACP